tiprankstipranks
Advertisement
Advertisement
Cue Biopharma to present new in vitro data for CUE-401
PremiumThe FlyCue Biopharma to present new in vitro data for CUE-401
1M ago
Cue Biopharma Sets 2026 Annual Meeting, Proposal Deadlines
Premium
Company Announcements
Cue Biopharma Sets 2026 Annual Meeting, Proposal Deadlines
2M ago
Cue Biopharma announces preclinical safety, tolerability data for CUE-401
Premium
The Fly
Cue Biopharma announces preclinical safety, tolerability data for CUE-401
2M ago
Cue Biopharma prices 35.7M shares at 28c in underwritten public offering
PremiumThe FlyCue Biopharma prices 35.7M shares at 28c in underwritten public offering
4M ago
Cue Biopharma offers to sell common stock, no amount given
Premium
The Fly
Cue Biopharma offers to sell common stock, no amount given
4M ago
Cue Biopharma Releases Updated Corporate Presentation
Premium
Company Announcements
Cue Biopharma Releases Updated Corporate Presentation
5M ago
Cue Biopharma, ImmunoScape enter strategic collaboration, license agreement
PremiumThe FlyCue Biopharma, ImmunoScape enter strategic collaboration, license agreement
5M ago
Cue Biopharma Partners with ImmunoScape for Cell Therapy
Premium
Company Announcements
Cue Biopharma Partners with ImmunoScape for Cell Therapy
5M ago
Cue Biopharma Appoints Usman Azam as New CEO
Premium
Company Announcements
Cue Biopharma Appoints Usman Azam as New CEO
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100